Use of Parkinson’s Disease Biosamples

MJFF biosamples are available for every stage of intended use, including target identification and validation, assay development and validation, biomarker discovery, biomarker replication, biomarker verification and assessment of disease progression. MJFF is especially interested in the following:

• Assay development and validation for novel Parkinson’s disease biomarkers
• Biomarker replication and validation of promising measures that associate with Parkinson’s or Parkinson’s progression
• Target discovery and validation using human biosamples

Funding: $300,000 total 

Duration: 2 years 

Research Authority due date: 17.9.19

Pre proposal (required) due date:  24.9.19

Full application due date: 17.1.20